A carcinogenicity study in mice of a ß-adrenergic antagonist, primidolol; Increased total tumour incidence without tissue specificity
- 1 January 1981
- journal article
- research article
- Published by Elsevier in Toxicology
- Vol. 21 (4) , 279-290
- https://doi.org/10.1016/0300-483x(81)90143-8
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Effect of single and twice daily doses of primidolol (UK-11,443) in hypertensionCurrent Medical Research and Opinion, 1980
- Influence of biogenic amines on the growth of xenografted human colorectal carcinomasBritish Journal of Cancer, 1979
- Tumorigenicity Assays of Sotalol Hydrochloride in Rats and MiceThe Journal of Clinical Pharmacology, 1979
- Preclinical toxicologic evaluation of nadolol, a new β-adrenergic antagonistToxicology and Applied Pharmacology, 1978
- Blockade of isoprenaline‐induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.British Journal of Clinical Pharmacology, 1978
- PROPRANOLOL AND PROLACTINThe Lancet, 1977
- Lack of carcinogenicity of oxprenolol, a β-adrenergic blocking agentToxicology and Applied Pharmacology, 1977
- Histopathology of primary lung tumours in the mouseThe Journal of Pathology, 1969
- Carcinogenesis and sanityFood and Cosmetics Toxicology, 1968
- Carcinogenic Action of PronethalolBMJ, 1963